{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "68974-200",
      "generic_name": "sparsentan",
      "labeler_name": "Travere Therapeutics, Inc.",
      "brand_name": "FILSPARI",
      "active_ingredients": [
        {
          "name": "SPARSENTAN",
          "strength": "200 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "68974-200-30",
          "description": "30 TABLET, FILM COATED in 1 BOTTLE (68974-200-30)",
          "marketing_start_date": "20230217",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Travere Therapeutics, Inc."
        ],
        "rxcui": [
          "2630540",
          "2630546",
          "2630548",
          "2630550"
        ],
        "spl_set_id": [
          "d7354af1-f304-f4d9-e053-2995a90ab219"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175581",
          "N0000175364",
          "N0000175561",
          "N0000180999",
          "N0000187064",
          "N0000185507",
          "N0000185607",
          "N0000185503",
          "N0000190113"
        ],
        "pharm_class_epc": [
          "Endothelin Receptor Antagonist [EPC]",
          "Angiotensin 2 Receptor Blocker [EPC]"
        ],
        "pharm_class_moa": [
          "Endothelin Receptor Antagonists [MoA]",
          "Angiotensin 2 Type 1 Receptor Antagonists [MoA]",
          "Cytochrome P450 2B6 Inducers [MoA]",
          "Cytochrome P450 2C9 Inducers [MoA]",
          "Cytochrome P450 2C19 Inducers [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]"
        ],
        "unii": [
          "9242RO5URM"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "2299f93e-22fc-48ac-8d06-c558fc57bb0d",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20230217",
      "product_id": "68974-200_2299f93e-22fc-48ac-8d06-c558fc57bb0d",
      "application_number": "NDA216403",
      "brand_name_base": "FILSPARI",
      "pharm_class": [
        "Angiotensin 2 Receptor Blocker [EPC]",
        "Angiotensin 2 Type 1 Receptor Antagonists [MoA]",
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Cytochrome P450 2B6 Inducers [MoA]",
        "Cytochrome P450 2C19 Inducers [MoA]",
        "Cytochrome P450 2C9 Inducers [MoA]",
        "Endothelin Receptor Antagonist [EPC]",
        "Endothelin Receptor Antagonists [MoA]",
        "P-Glycoprotein Inhibitors [MoA]"
      ]
    }
  ]
}